SPY303.62+0.65 0.21%
DIA254.34-0.01 0.00%
IXIC9,451.47+82.48 0.88%

Puma Biotechnology Q1 Adj. EPS $(0.200) Beats $(0.730) Estimate, Sales $48.600M Beat $47.060M Estimate

Puma Biotechnology (NYSE:PBYI) reported quarterly losses of $(0.200) per share which beat the analyst consensus estimate of $(0.730) by 72.6 percent. This is a 23.08 percent increase over losses of $(0.260) per share

Benzinga · 05/07/2020 20:13

Puma Biotechnology (NYSE:PBYI) reported quarterly losses of $(0.200) per share which beat the analyst consensus estimate of $(0.730) by 72.6 percent. This is a 23.08 percent increase over losses of $(0.260) per share from the same period last year. The company reported quarterly sales of $48.600 million which beat the analyst consensus estimate of $47.060 million by 3.27 percent. This is a 50.96 percent decrease over sales of $99.100 million the same period last year.